PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Overview of attention for article published in Breast Cancer Research, October 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 3 X users
patent: 48 patents
wikipedia: 9 Wikipedia pages

Readers on

mendeley: 804 Mendeley

Summary News Blogs Policy documents X Patents Wikipedia

So far, Altmetric has seen 9 citations on 9 Wikipedia pages.

Turkish

Palbociclib

Cited by user Pixel0525 on 09 Jan 2024

Palbociclib, Pfizer tarafından HR-pozitif ve HER2-negatif meme kanserinin tedavisi için geliştirilen bir ilaçtır.

Italian

Palbociclib

Cited by user Vamos95 on 06 Mar 2021

Portuguese

Palbociclib

Cited by user JMagalhães on 21 Dec 2020

Palbociclib, comercializado sob a marca Ibrance, entre outras, é um medicamento desenvolvido pela Pfizer para o tratamento de cancro da mama dos tipos HR-positivo e HER2-n…

Japanese

パルボシクリブ

Cited by user Topaz2 on 02 Jun 2020

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity, including 5 additional Wikipedia articles.